Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The ovarian-related effects of polystyrene nanoplastics on human ovarian granulosa cells and female mice. | Ecotoxicol Environ Saf | 2023 | 37087970 | PubTator, text mining | PubMed |
| Targeting neddylation as a novel approach to lung cancer treatment (Review). | Int J Oncol | 2023 | 37083098 | PubTator, text mining | PubMed |
| LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism. | Nat Commun | 2023 | 37080959 | PubTator, text mining | PubMed |
| Obscurin Rho GEF domains are phosphorylated by MST-family kinases but do not exhibit nucleotide exchange factor activity towards Rho GTPases in vitro. | PLoS One | 2023 | 37079638 | PubTator, text mining | PubMed |
| Retraction Note: Mst1 overexpression combined with Yap knockdown augments thyroid carcinoma apoptosis via promoting MIEF1-related mitochondrial fission and activating the JNK pathway. | Cancer Cell Int | 2023 | 37069660 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG15: A promising target in human cancers. | Front Oncol | 2023 | 37056344 | PubTator, text mining | PubMed |
| Research trends of omics in ulcerative colitis: A bibliometric analysis. | Front Med (Lausanne) | 2023 | 37051213 | PubTator, text mining | PubMed |
| Potential Effect of Glutamine in the Improvement of Intestinal Stem Cell Proliferation and the Alleviation of Burn-Induced Intestinal Injury via Activating YAP: A Preliminary Study. | Nutrients | 2023 | 37049605 | PubTator, text mining | PubMed |
| HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer. | BMC Cancer | 2023 | 37038139 | PubTator, text mining | PubMed |
| Mammalian sterile 20-like kinase 1 acts as a candidate biomarker of mortality of emergency surgical repair for acute type a aortic dissection. | BMC Cardiovasc Disord | 2023 | 37038132 | PubTator, text mining | PubMed |
Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area. | Front Med (Lausanne) | 2023 | 37035320 | PubTator, text mining | PubMed |
| Viewing entrepreneurship through a goal congruity lens: The roles of dominance and communal goal orientations in women's and men's venture interests. | Front Psychol | 2023 | 37034920 | PubTator, text mining | PubMed |
| Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomes. | medRxiv | 2023 | 37034728 | PubTator, text mining | PubMed |
| Emerging role of engineered exosomes in nonalcoholic fatty liver disease. | World J Hepatol | 2023 | 37034232 | PubTator, text mining | PubMed |
| Cyr61 Mediates Angiotensin II-Induced Podocyte Apoptosis via the Upregulation of TXNIP. | J Immunol Res | 2023 | 37032654 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus. | Signal Transduct Target Ther | 2023 | 37015918 | PubTator, text mining | PubMed |
| CHARMM-GUI Membrane Builder: Past, Current, and Future Developments and Applications. | J Chem Theory Comput | 2023 | 37014931 | PubTator, text mining | PubMed |
| Glycosphingolipids within membrane contact sites influence their function as signaling hubs in neurodegenerative diseases. | FEBS Open Bio | 2023 | 37014126 | PubTator, text mining | PubMed |
| DNAJB4 promotes triple-negative breast cancer cell apoptosis via activation of the Hippo signaling pathway. | Discov Oncol | 2023 | 37012515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=26